Balchem Corporation
NASDAQ:BCPCChemicals - Specialty
+$1.03 today
- Market cap
- $5.36B
- Beta
- 0.83
- P/E (TTM)
- 33.8
- EPS (TTM)
- $4.90
- Dividend yield
- 0.58%
Volume 0.21M
Average 0.21M
BCPC Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Balchem CorporationNASDAQ: BCPC
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development declines year over year
Q3 FY2026 research & development of $5.34M fell 42.7% year over year, behind the -10.1% change in trailing-twelve-month research & development. Sequentially, it rose 17.8% from the prior quarter. Over 3 fiscal years it compounded at +14.9% a year.
Context
- Research & development amounted to 1.8% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -42.7% toward the trailing-twelve-month pace of -10.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 18.51M USD
- Year-over-year change
- +10.2%
- 4-year CAGR
- +8.2%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 18.51M | +10.2% |
| FY2024 | 2024-12-31 | 16.79M | +11.6% |
| FY2023 | 2023-12-31 | 15.05M | +23.4% |
| FY2022 | 2022-12-31 | 12.19M | -9.9% |
| FY2021 | 2021-12-31 | 13.52M | — |
Research & Development vs competitors
How BCPC compares with its peers on the latest reported figures
- BCPC's LTM Sep 2026 research & development of $20.81M is the 6th highest of the 11 companies compared; the peer median is $26.05M.
- Its year-over-year change of -10.1% is the 6th highest of 8, against a peer median of +0.9%.
- Research & development amounts to 1.9% of revenue for BCPC, versus a peer median of 1.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $684M | +0.9% | +4.8% | 6.9% | |
| LTM Jun 2026 | $246M | -7.2% | -1.1% | 2.8% | |
| LTM Mar 2026 | $59.62M | +6.3% | -3.8% | 2.5% | |
| LTM Jun 2026 | $55M | +3.8% | -0.6% | 3.0% | |
| LTM Jun 2026 | $52.1M | +4.0% | +9.6% | 2.8% | |
| LTM Sep 2026 | $20.81M | -10.1% | +14.9% | 1.9% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding BCPC) | $26.05M | +0.9% | -0.6% | 1.3% | |
Competitors are the stored peer set for BCPC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 799.02M | 942.36M | 922.44M | 953.68M | 1.04B |
| Cost of Revenue | 555.85M | 661.91M | 620.38M | 617.48M | 666.53M |
| Gross Profit | 243.17M | 280.45M | 302.06M | 336.21M | 370.63M |
| Gross Margin | 30.4% | 29.8% | 32.7% | 35.3% | 35.7% |
| Research & Development | 13.52M | 12.19M | 15.05M | 16.79M | 18.51M |
| Selling, General & Admin | 102.15M | 123.07M | 130.13M | 136.5M | 142.8M |
| Operating Expenses | 115.67M | 135.27M | 142.86M | 153.3M | 152.3M |
| Depreciation & Amortization | 48.88M | 51.85M | 54.94M | 47.97M | 45.69M |
| EBITDA | 176.57M | 195.87M | 214.81M | 230.95M | 254.94M |
| EBITDA Margin | 22.1% | 20.8% | 23.3% | 24.2% | 24.6% |
| Operating Income | 127.5M | 145.19M | 159.19M | 182.91M | 218.33M |
| Operating Margin | 16.0% | 15.4% | 17.3% | 19.2% | 21.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.46M | 10.27M | 22.61M | 16.53M | 10.22M |
| Other Income / Expenses | (2.27M) | (11.44M) | (21.93M) | (16.46M) | (19.3M) |
| Income Before Tax | 125.23M | 133.75M | 137.26M | 166.45M | 199.03M |
| Pre-Tax Margin | 15.7% | 14.2% | 14.9% | 17.5% | 19.2% |
| Income Tax Expense | 29.13M | 28.38M | 28.72M | 37.98M | 44.19M |
| Net Income | 96.1M | 105.37M | 108.54M | 128.48M | 154.85M |
| Net Margin | 12.0% | 11.2% | 11.8% | 13.5% | 14.9% |
| EPS (Basic) | 2.98 | 3.29 | 3.38 | 3.97 | 4.80 |
| EPS (Diluted) | 2.94 | 3.25 | 3.35 | 3.93 | 4.75 |
| Weighted Avg Shares | 32.22M | 32.02M | 32.11M | 32.33M | 32.6M |
| Weighted Avg Shares (Diluted) | 32.67M | 32.39M | 32.45M | 32.72M | 32.6M |
Balchem Corporation
NASDAQ:BCPC
Intrinsic Alpha fair value
Locked
Current Price
$168.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.